Protein complexes having factor VIII:C activity and production thereof
AssigneeChiron Corporation
InventorsBarbara Chapman, Rae Lyn Burke, Mirella Ezban Rasmussen, Jan Moller Mikkelson
Life of this patent
Estimating the term…
Loading patent…
AssigneeChiron Corporation
InventorsBarbara Chapman, Rae Lyn Burke, Mirella Ezban Rasmussen, Jan Moller Mikkelson
Estimating the term…
Recombinant protein complexes having human Factor VIII:C activity are expressed in a eukaryotic host cell by transforming the host cell with first and second expression cassettes encoding a first polypeptide substantially homologous to human Factor VIII:C A domain and a second polypeptide substantially homologous to human Factor VIII:C C domain, respectively. In the present invention, the first polypeptide may be extended having at its C-terminal a human Factor VIII:C B domain N-terminal peptide, a polypeptide spacer of 3-40 amino acids, and a human Factor VIII:C B domain C-terminal peptide. Expression of the second polypeptide is improved by employing an α1-antitrypsin signal sequence.
A method for producing a recombinant protein complex having human Factor VIII:C activity, said complex comprising a first polypeptide homologous to the A domain of human Factor VIII:C, and a second polypeptide having homology to the C domain of human Factor VIII:C, but lacking all/or a substantial portion of the B domain of human Factor VIII:C, which method comprises:
A DNA composition for transforming a eukaryotic host cell to obtain expression of a recombinant protein complex having human Factor VIII:C activity, wherein said DNA composition comprises:
A polypeptide having human Factor VIII:C activity when combined with a polypeptide homologous to human Factor VIII:C Mr 80 K protein, wherein said polypeptide comprises from N-terminal to C-terminal:
Dependencies are inferred from the claim text.